Brief: Lexeo Therapeutics Announces $80 Million Equity Financing
27/05/2025 13:21
May 27 (Reuters) - Lexeo Therapeutics Inc LXEO.O: LEXEO THERAPEUTICS ANNOUNCES $80 MILLION EQUITY FINANCING TO FURTHER ADVANCE DEVELOPMENT OF TRANSFORMATIVE GENETIC MEDICINES FOR CARDIOVASCULAR DISEASES LEXEO THERAPEUTICS - FINANCING LED BY FRAZIER LIFE SCIENCES AND JANUS HENDERSON INVESTORS Source text: ID:nGNX2hQWSl Further company coverage: LXEO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lexeo Therapeutics
See all newsBrief: Lexeo Therapeutics Enters Into Agreement To Acquire Mantle Therapeutics And Announces Multiple New Strategic Collaborations To Expand Leadership In Friedreich Ataxia
Brief: Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (Rmat) Designation For Lx2020
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex
U.S. STOCKS ON THE MOVE-Datadog, Terawulf
Lexeo rises as co sets late-stage trial plan for gene therapy in rare heart disease